Podcasts about cald

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - بسیاری از افراد جوامع دارای پیش‌زمینه‌های فرهنگی و زبانی متنوع (CALD)، به‌ویژه زنان، از مراقبت‌های پیشگیرانه سرطان خودداری می‌کنند یا آن را به تعویق می‌اندازند.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - 다양한 문화적, 언어적 배경이 사람들 중 특히 여성들은 검사에 대한 두려움과 문화적 낙인 때문에 필수적인 건강 검진을 꺼리는 경향이 있습니다.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Nhiều người trong cộng đồng đa dạng văn hóa và ngôn ngữ, đặc biệt là phụ nữ, đang tránh hoặc trì hoãn việc chăm sóc phòng ngừa ung thư.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Многие представители культурных и языковых меньшинств, особенно женщины, избегают или откладывают профилактические обследования на рак.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Багато людей із етнічних спільнот, особливо жінки, уникають або відкладають профілактичне лікування раку...

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - ผู้คนจากชุมชนที่มีความหลากหลายทางวัฒนธรรมและภาษา (CALD) โดยเฉพาะผู้หญิง กำลังหลีกเลี่ยงหรือเลื่อนการตรวจคัดกรองมะเร็งเชิงป้องกันออกไป

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Muchas personas de comunidades multiculturales, especialmente las mujeres, evitan o retrasan la atención médica preventiva relacionada con el cáncer.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - 文化的・言語的に多様な（CALD）コミュニティーの多く、特に女性たちが、がんの予防医療を避けがちなのはなぜでしょうか。

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Viele Menschen aus kulturell und sprachlich diversen Gemeinschaften, insbesondere Frauen, vermeiden oder verzögern die präventive Krebsbehandlung.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Mnoge osobe iz kulturno i jezički raznolikih zajednica (CALD), posebno žene, izbjegavaju ili odgađaju preventivnu zaštitu od raka.

Many people from CALD communities, especially women, are avoiding or delaying preventative cancer care. - Jinên ji paşerehên çand û zimanên cihêreng ji ber tirs û şerma çandî ji têstên tenduristiyê yên pêwîst e weke penceşêrê xwe bê par dikin.

This week Monique chats with Sharen Lui. Sharen is a neurodivergent Educational and Developmental Psychologist, and the Director of Sprout Psychology Melbourne. Sharen specialises in neurodivergence within Asian communities, supporting families with assessments, therapy, and culturally responsive mental health support. Sharen and Monique cover: What neurodivergence means to Sharen and the driving force behind establishing Sprout Psychology in Melbourne. Sharen’s path to discovering her own neurodivergence and the role of her cultural identity in this process. The impact of words and language on the perception of neurodivergence in Chinese culture. The importance of meeting Culturally and Linguistically Diverse (CALD) families and individuals ‘where they are at’ when working therapeutically. How do Chinese cultural norms interact with the experience of neurodivergence? Sharen talks Monique through filial piety, gendered expectations for women, and behavioural norms around what it means to be a ‘mature’ adult within Chinese culture. The layers of masking for neurodivergent Chinese folk. Barriers to accessing culturally competent neurodiversity-affirming health care in Australia for neurodivergent Chinese folk, and Sharen’s work in this space. Things to keep in mind when working with CALD groups. Find Sharen at her Melbourne-based practice – Sprout Psychology. Monique and Sharen also gave a shout-out to LOAPAC (The League of Autistic Psychologists and Affirming Colleagues), which you can check out to find an affirming psychologist. Got questions for us?? Come along to our LIVE Q&A event! Held online on 27th June (with replay available to all ticket holders). Grab a ticket here and submit your question! Enjoyed the episode and want to support us further? Join our Patreon community! Patreon subscribers receive ad-free episodes, basic episode transcripts from Season 4 onwards, access to a monthly live zoom hang out, 50% off our episode articles, plus bonus monthly content (depending on subscription tier). Check out our Patreon page to support us, as we aim to make quality mental health care information accessible to everyone: www.patreon.com/ndwomanpod. Want polished copies of our episodes in beautiful and readable pdf article format? Grab them here. Contact us at ndwomanpod@gmail.com, or visit our website: www.ndwomanpod.comSee omnystudio.com/listener for privacy information.

We welcome Anne Altamore, founder and owner of Life After IVF Counselling, Psychotherapy and Coaching. Anne shares her insights on the importance of visibility, the emotional toll of exclusion, and how social media can be used to broaden conversations about childlessness. We tackle International Women's Day, discussing the need for allyship, the gendered expectations placed on women, and how we can all work towards a more inclusive and equal society that is inclusive to childless women. We're talking about … The emotional impact of childlessness in professional and personal spaces The importance of acknowledging childlessness in the International Women's Day narrative Breaking stereotypes and gender roles in society How men can be allies and support gender equality The historical and modern-day challenges we face in being heard and valued Follow our guests Connect with Anne Altamore on LinkedIn for helpful posts on childlessness and workplace inclusivity, You can follow her on Instagram and Facebook too. Anne is a postgraduate degree qualified counsellor holding a Masters in Counselling and Psychotherapy and experienced in supporting grief of involuntary childlessness with many communities - CALD, heterosexual men and women as well as in the LGBTQIA+ community.  More to explore Join in the conversation in our Full Stop online community for childless people from £5 a month with a free month on us Buy a Virtual Coffee to keep our podcast free to air and accessible to everyone. Download Finding Connections, a booklet by Sarah and Berenice with links to groups, books, events and other resources for childless people. We hope you find it helpful. Join our newsletter for behind the scenes info, wellbeing tips and news from the wider community and alerts to our podcast as it publishes direct to your inbox. Access the Transcript

Episode #314: Celito Arlegue, the Executive Director of the Council of Asian Liberals and Democrats (CALD), offers a reflective account of his organization's involvement with Myanmar. He discusses CALD's initial engagement with Myanmar's National League for Democracy (NLD), providing training and support leading up to the 2015 elections, and recalls the optimism of that period, with many NLD members showing remarkable resilience despite years of imprisonment and torture. These experiences were life-changing for Arlegue, who was struck by the leaders' focus on national reconciliation and democratic progress instead of any justifiable animosity toward the military.However, Arlegue also admits that CALD was unprepared for the challenges the NLD would face in governance, particularly during the Rohingya crisis. The complexities of this crisis strained relations between CALD and the NLD, as the organization struggled to balance its support for democracy with the need to address human rights violations. Arlegue expresses regret that CALD did not do more during this period, acknowledging the difficulty of navigating such a delicate situation.In the aftermath of the 2021 military coup, CALD's connections with Myanmar's democratic forces have become increasingly difficult to maintain, as many leaders are now in exile or imprisoned. Arlegue underscores the importance of international recognition for the National Unity Government (NUG) and calls for greater support for Myanmar's resistance forces, including military aid. Despite the challenges, Arlegue remains hopeful, recognizing the extraordinary courage and determination of the Myanmar people in their fight for democracy and human rights.“I have to say that I'm really surprised that ASEAN is not recognizing this as a regional security issue,” he says. “The mere fact that it's happening within our borders, and as ASEAN, we could not do anything about it! It really baffles me why ASEAN is not doing enough on this particular issue.” Arlegue further calls on ASEAN to recognize the NUG and CRPH as “the legitimate voices of the Myanmar people.”

In this episode, Dr. T chats with Mrs Ennia Jones, founder of A Splash of Colour Swimming Incorporated, which is a transformative not-for-profit learn-to-swim program, designed to break down the mental, financial, social and cultural barriers preventing culturally and linguistically diverse (CALD) individuals from acquiring essential swimming and water safety skills. The conversation delves deep into the complexities of becoming a member at Splash of Colours Swimming, and processes one go through to completing the program and future plans.  Ennia is dedicated to creating a supportive and culturally tailored environment where participants not only gain critical swimming skills, but also access long-term pathways to improved water safety, mental and physical health and social inclusion. Her work continues to inspire others, showing how local initiatives can create meaningful, lasting change and foster empowerment, health and inclusivity within communities. Thanks for choosing the Visions & Tones Podcast 

Given the significant drowning and near-drowning statistics within CALD communities, Victoria Police is issuing an important safety message to the public this summer. SBS Hindi discusses drowning prevention and effective safety practices with Inspector Sonali Deshpande.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - አውስትራሊያውያን በዓመት በቁማር 32 ቢሊየን ዶላር ያጣሉ፤ በግለሰብ ደረጃ ከማናቸው አገር በበለጠ። በተለየ ሁኔታም ዝንቅ ማኅበረሰባቱ ላይ ጉዳትን እያስከተለ ነው።

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Становници Аустралије изгубе на коцки 32 милијарде долара годишње, што је већи износ по особи него у било којој другој земљи света. Проблем коцкања на различите начине погађа мултикултуралне заједнице и такође има различит утицај на људе.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Warga Australia kehilangan $32 miliar per tahun karena perjudian – lebih banyak per orangnya dibandingkan negara lain. Dan hal ini berdampak pada beragam komunitas secara berbeda.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - آسترالیایی‌ها سالانه ۳۲ میلیارد دالر را بر اثر قمار زدن از دست می‌دهند. این مبلغ در آزای هر تن بیشتر از هر کشور دیگر در جهان است.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - ਆਸਟ੍ਰੇਲੀਆ ਦੇ ਲੋਕ ਜੂਏ ਵਿੱਚ ਹਰ ਸਾਲ $32 ਬਿਲੀਅਨ ਗੁਆਉਂਦੇ ਹਨ ਜੋ ਕਿਸੇ ਵੀ ਹੋਰ ਦੇਸ਼ ਨਾਲੋਂ ਪ੍ਰਤੀ ਵਿਅਕਤੀ ਵੱਧ ਹੈ। ਇਹ ਬਹੁਤ ਸਾਰੇ ਭਾਈਚਾਰਿਆਂ ਨੂੰ ਵੱਖੋ-ਵੱਖਰੇ ਤੌਰ 'ਤੇ ਪ੍ਰਭਾਵਿਤ ਕਰ ਰਿਹਾ ਹੈ।

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Australci gube 32 milijarde dolara godišnje zbog kockanja – što je više po osobi nego u bilo kojoj drugoj državi. I ta činjenica različito utiče na različite zajednice.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - آسٹریلین شہری مجموعی طور پر ہر سال جوئے میں 32 بلین ڈالرز سے زیادہ ہار جاتے ہیں جبکہ یہ شرح فی کس کے اعتبار سے دنیا میں سب سے زیادہ ہے، جبکہ یہ صورتحال مختلف (متنوع پس منظر رکھنے والی ) کمیونٹیز کو مختلف انداز میں متاثر کر رہی ہے

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - استرالیاییها سالانه ۳۲ میلیارد دلار به دلیل قمار از دست میدهند که بیشتر از هر کشور دیگری برای هر فرد است. و به طور متفاوتی بر جوامع مختلف تأثیر می گذارد.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Ang mga Australyano ay nawawalan ng $32 bilyon bawat taon dahil sa pagsusugal - ito ang pinakamataas kumpara sa ibang bansa sa buong mundo. Paano nito naaapektuhan ang iba't ibang komunidad?

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Los australianos pierden 32 mil millones de dólares al año en juegos de azar, eso representa la tasa por persona más alta del mundo y está afectando a las comunidades de diferente forma.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - 호주인이 도박으로 인해 잃는 금액은 연간 320억 달러에 달합니다. 이는 다른 어느 나라보다 큰 1인당 손실액입니다. 또한 각 커뮤니티에 미치는 영향도 다릅니다.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Cờ bạc khiến người Úc mất 32 tỷ đô la mỗi năm, nhiều hơn bất kỳ quốc gia nào khác. Ngoài ra, nó còn có tác động khác nhau đến các nền văn hóa khác nhau.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - 澳洲人一年在賭博上損失320億元，人均數字是全球第一。賭博的危險，對多元文化社區可能有不同的影響。

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Australijczycy wydają na hazard aż 32 miliardy dolarów rocznie. Według najnowszych danych Departamentu Skarbu Queensland to więcej na osobę niż w jakimkolwiek innym kraju na świecie.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - オーストラリアでギャンブルをした人たちが負けた金額は、１年間で総額320億オーストラリアドルに上ります。国民１人当たりで比べると、世界のどの国よりも高い金額です。

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Австраличууд мөрийтэй тоглоомд жилд 32 тэрбум доллар алдаж байна — энэ нь хүн амын тоогоороо харьцуулахад бусад бүх улс орноос хавьгүй их мөнгөний тоо юм. Олон янзын гарал үүсэлтэй нийгэмлэгүүдэд мөрийтэй тоглоом өөр өөрөөр нөлөөлж байна.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - গত ১২ মাসে প্রায় ৭০ শতাংশেরও বেশি প্রাপ্তবয়স্ক মানুষ জুয়া খেলায় অংশগ্রহণ করেছে। এ-কথা তাই সহজেই বলা যায় যে, অস্ট্রেলিয়ানরা জুয়া খেলতে পছন্দ করে। কিন্তু ডাইভার্স কম্যুনিটির বিভিন্ন সদস্যের ওপর জুয়া খেলার প্রভাব এবং ক্ষতি হওয়ার সম্ভাবনা বিভিন্ন রকমের হয়ে থাকে।

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - ប្រជាជនអូស្ត្រាលីខាតបង់ប្រាក់អស់ បីម៉ឺនពីរពាន់លានដុល្លារក្នុងមួយឆ្នាំក្នុងការលេងល្បែងស៊ីសង គឺច្រើនជាងជាមធ្យមក្នុងមនុស្សម្នាក់ៗ នៅក្នុងប្រទេសផ្សេងទៀតនៅលើពិភពលោក។ ហើយវាជះឥទ្ធិពលដល់សហគមន៍ចម្រុះខុសៗពីគ្នា។

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - 澳大利亚人每年因赌博而损失320亿澳元，人均损失超过全球任何其他国家。而赌博对不同社区的影响也不尽相同。（点击上方收听音频）

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - अस्ट्रेलियनहरूले एक वर्षमा जुवामा ३२ अर्ब डलर गुमाएका छन् - जुन प्रतिव्यक्ति दर विश्वको कुनै पनि राष्ट्रको तुलनामा सबैभन्दा धेरै हो। यसले विविध समुदायहरूलाई फरक-फरक तरिकाले प्रभाव पारिरहेको छ।

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - ชาวออสเตรเลียสูญเงินกว่า 32 ล้านดอลลาร์ต่อปีให้กับการพนัน และนั่นเป็นตัวเลขต่อหัวที่สูงกว่าทุกประเทศ อะไรทำให้ชุมชนต่างภาษาในออสเตรเลียได้รับผลกระทบกว่าชุมชนอื่น?

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - ऑस्ट्रेलिया के लोग जुए में हर साल 32 बिलियन डॉलर खो देते हैं । किसी भी अन्य देश की तुलना में यह प्रति व्यक्ति ज़्यादा है और इसका अलग-अलग समुदायों पर अलग-अलग असर पड़ रहा है।

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - يخسر الأستراليون 32 مليار دولار سنوياً بسبب المقامرة، وهو ما يفوق أي دولة أخرى من حيث الإنفاق الفردي. لكن تأثير هذه الظاهرة يختلف بين المجتمعات المتنوعة في أستراليا، حيث يعاني بعض المهاجرين من آثار أكثر خطورة.

Australians lose $32 billion a year to gambling — more per person than any other nation. And it's affecting diverse communities differently. - Οι Αυστραλοί χάνουν 32 δισεκατομμύρια δολάρια ετησίως στα τυχερά παιχνίδια - περισσότερα ανά άτομο σε σχέση με οποιοδήποτε άλλο κράτος. Και αυτό επηρεάζει διαφορετικά τις διαφορετικές κοινότητες.

"Queering the Air" on 3CR recently aired an insightful episode with our lovely guest, the gorgeous Kavitha Sivasamy, a beautiful yet powerful lawyer with a big heart who advocates for the LGBTIQA+ and CALD communities.Kavitha is a proud transgender woman of colour of Sri Lankan Tamil descent. She had been working as a lawyer for five years and in the legal sector for nearly nine years, with extensive experience in the community and not-for-profit sectors. Her work focused particularly on family violence, refugee law, asylum seeker experiences, LGBTIQA+ justice (especially the rights and freedoms of trans and gender-diverse people), and trauma-informed communication.We spoke with Kavitha up close and personal, delving into her life, her journey as a transwoman of colour and the impact of her work. In this special episode, we also discussed the significance of the 16 Days of Activism, in line with the global campaign to say no to gender-based violence. Kavitha shared her insights on how gender violence intersects with the experiences of trans and gender-diverse people, as well as how she continues to advocate for a safer, more inclusive society.Kavitha had recently moved to Melbourne from Canberra to launch and run a new program called Justice Q at the South-East Monash Legal Service (SMLS). Justice Q provides free legal advice and assistance to LGBTIQA+ people, with a special focus on the Casey, Cardinia, and Greater Dandenong regions, as well as the southeast corridor of Greater Metropolitan Melbourne. Prior to this, Kavitha had worked at Legal Aid ACT, Canberra Community Law, Slater and Gordon, Maurice Blackburn Lawyers, and Playfair Visa and Migration Services, in addition to volunteering at numerous community legal centres while completing her studies at the University of Sydney.Outside of work, Kavitha loved spending time with her puppy and friends. She was also passionate about artistic and creative pursuits, having been a performer in Canberra before moving to Naarm. Earlier this year, she played a lead role in Bring It On: The Musical with the Canberra Philharmonic Society. Resources:101 on 16 Days of Activism (Quick guide to the 16 Days of Activism against Gender-Based Violence | Respect Victoria)Healthy Relationship: https://www.transfemme.com.au/Song aired on today's podcast:Music by MadonnaEnjay Enjaami by Dhee ft Arivu and Santhosh NarayanGreedy by Tate McRae 

Jim Betts, Secretary of the Department of Infrastructure, Transport, Regional Development, Communications and the Arts, talks about shaping his role as APS CALD Champion and why he wants leaders to take action to achieve equality.Our recent episode on CALD representation in the senior executive left many of us and our listeners humbled. Australia's public service is diverse, yet there is still some way to go to achieve true equality for CALD employees in its senior ranks.This time, Jim Betts joins host David Pembroke, CEO of contentgroup, to talk about the Secretaries Board's CALD compact to support inclusion and equality at the leadership level. Jim talks about his role as an advocate, encouraging other secretaries to champion the cause of CALD employees.Jim also talks about his love for creating environments where others can thrive and bring their authentic selves to work and shaking up people's pre-conceptions of what a senior public servant looks like. Key tips:As a leader, you don't need to speak in management jargon to succeed, if that's not who you are. You can be your authentic self.CALD employees shouldn't have to drive change alone – be a champion for their cause.To create a sense of belonging, support your CALD employees in telling their stories and empathise with them.Show notes:Secretaries Board communique: 9 October 2024 | Department of the Prime Minister and CabinetWhy cultural and linguistic diversity matters | Work with Purpose Hosted on Acast. See acast.com/privacy for more information.

In a special co-branded episode between Oncology On the Go hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Alexis K. Kuhn, PharmD, BCOP, spoke with Katie Bruce, PharmD, BCPPS, and Susie Long, PharmD, about the use of approved cell-based gene therapies for patients with sickle cell disease, beta thalassemia, adrenoleukodystrophy (ALD), and metachromatic leukodystrophy (MLD). These panelists shared the pharmacist's perspective on ensuring quality care with these ex vivo gene therapies across all treatment phases, including mobilization, conditioning, and infection prophylaxis. Kuhn is an ambulatory Pediatric Hematology/Oncology/BMT Pharmacist at the Mayo Clinic in Rochester, Minnesota, and an assistant professor of Pharmacy at the Mayo Clinic College of Medicine. Bruce is a pediatric clinical pharmacy specialist at the Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy program of Tristar Centennial Medical Center in Nashville, Tennessee. Long is a pediatric clinical pharmacist in the Blood and Marrow Team at the University of Minnesota Masonic Children's Hospital. Specifically, the panelists spoke about the use of agents like elivaldogene autotemcel (Skysona) and atidarsagene autotemcel (Lenmeldy), which are FDA-approved for ALD and MLD, respectively. They also discussed the use of exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), which the FDA approved for treating patients 12 years and older with sickle cell disease in December 2023. The conversation broke down each stage of treatment, detailing optimal strategies for the cell manufacturing and storing processes as well as the management of toxicities like cytopenias. They also reviewed key considerations during the post-infusion period that may help maximize the quality of life for patients after they complete their therapy. “It has been so amazing to be able to be a part of gene therapy and gene editing,” Bruce stated regarding the potential long-term impacts of these treatments. “We have patients who are able to hold full-time jobs they never were able to have before. We have patients who are climbing mountains and backpacking through Europe, which would have never been an option before because their sickle cell disease would have prevented them from [doing] that…. It's not an easy process, and it has a lot of steps for the patient to go through, but the reward at the end of it all is worth it.” References 1. bluebird bio receives FDA accelerated approval for SKYSONA® gene therapy for early, active cerebral adrenoleukodystrophy (CALD). News release. bluebird bio, Inc. September 16, 2022. Accessed October 7, 2024.https://tinyurl.com/mp8crxes 2. FDA approves first gene therapy for children with metachomatic leukodystrophy. New release. FDA. March 18, 2024. Accessed October 7, 2024. https://tinyurl.com/mrh659yk 3. FDA approves first gene therapies to treat patients with sickle cell disease. News release. FDA. December 8, 2023. Accessed October 7, 2024. https://tinyurl.com/3zbdnf4c

In a special co-branded episode between Oncology On the Go hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Alexis K. Kuhn, PharmD, BCOP, spoke with Katie Bruce, PharmD, BCPPS, and Susie Long, PharmD, about the use of approved cell-based gene therapies for patients with sickle cell disease, beta thalassemia, adrenoleukodystrophy (ALD), and metachromatic leukodystrophy (MLD). These panelists shared the pharmacist's perspective on ensuring quality care with these ex vivo gene therapies across all treatment phases, including mobilization, conditioning, and infection prophylaxis. Kuhn is an ambulatory Pediatric Hematology/Oncology/BMT Pharmacist at the Mayo Clinic in Rochester, Minnesota, and an assistant professor of Pharmacy at the Mayo Clinic College of Medicine. Bruce is a pediatric clinical pharmacy specialist at the Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy program of Tristar Centennial Medical Center in Nashville, Tennessee. Long is a pediatric clinical pharmacist in the Blood and Marrow Team at the University of Minnesota Masonic Children's Hospital. Specifically, the panelists spoke about the use of agents like elivaldogene autotemcel (Skysona) and atidarsagene autotemcel (Lenmeldy), which are FDA-approved for ALD and MLD, respectively. They also discussed the use of exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), which the FDA approved for treating patients 12 years and older with sickle cell disease in December 2023. The conversation broke down each stage of treatment, detailing optimal strategies for the cell manufacturing and storing processes as well as the management of toxicities like cytopenias. They also reviewed key considerations during the post-infusion period that may help maximize the quality of life for patients after they complete their therapy. “It has been so amazing to be able to be a part of gene therapy and gene editing,” Bruce stated regarding the potential long-term impacts of these treatments. “We have patients who are able to hold full-time jobs they never were able to have before. We have patients who are climbing mountains and backpacking through Europe, which would have never been an option before because their sickle cell disease would have prevented them from [doing] that…. It's not an easy process, and it has a lot of steps for the patient to go through, but the reward at the end of it all is worth it.” References bluebird bio receives FDA accelerated approval for SKYSONA® gene therapy for early, active cerebral adrenoleukodystrophy (CALD). News release. bluebird bio, Inc. September 16, 2022. Accessed October 7, 2024.  https://tinyurl.com/mp8crxes FDA approves first gene therapy for children with metachomatic leukodystrophy. New release. FDA. March 18, 2024. Accessed October 7, 2024. https://tinyurl.com/mrh659yk FDA approves first gene therapies to treat patients with sickle cell disease. News release. FDA. December 8, 2023. Accessed October 7, 2024. https://tinyurl.com/3zbdnf4c

On this episode, Dr Suzanne Akila, Jo Talbot, and Radi Kovacevic talk us through CALD representation in the public service, and what it will take for more culturally and linguistically diverse employees to succeed in the senior executive.Australia is a truly multicultural nation, with over 21 percent of the country's population born overseas. As this demographic has grown over the years, so has the number of culturally and linguistically diverse (CALD) employees in the public service. However, this isn't broadly reflected in the senior executive level. Earlier this year, the public service launched its CALD Employment Strategy to address this gap.On this episode of Work with Purpose, host David Pembroke speaks with Dr Suzanne Akila from the Department of Foreign Affairs and Trade and Radi Kovacevic from the Department of Home Affairs about their experience as CALD leaders in the public service. Leading the implementation of the CALD Employment Strategy, Jo Talbot from the Australian Public Service Commission also joins the discussion, focusing on how to create workplaces where everyone feels a sense of belonging.Discussed in this episode:· why cultural and linguistic diversity matters in the workplace· championing CALD employees in the APS· being curious about people's stories· the effects of othering· key initiatives under the CALD Employment Strategy· building cultural understanding· removing bias from recruitment processes· challenging what a good leader looks like· learning critical self-reflection· tips for aspiring CALD leaders.Show notes:· APS Culturally and Linguistically Diverse Employment Strategy and Action Plan | Australian Government· CALD network | Australian Public Service Commission· MOSAIC multicultural awareness digital magazine | APS Academy Hosted on Acast. See acast.com/privacy for more information.

Luna trecută a fost cea mai caldă lună iunie din istoria măsurătorilor meteo din România. Recordul anterior data din 2019. Concomitent cu valurile de caniculă, România este afectată de furtuni violente, care fac pagube în numeroase localități.

Holly Markwell the National Program Manager at The Dementia Centre explores the importance of providing opportunities for people that want to care for dementia at home, some of the complexities associated with doing so. She also touched on how dementia is seen from CALD perspectives, and the importance of learning about dementia.

Conversation with the University of Melbourne's Professor Jill Wigglesworth about translanguaging, language as a vehicle for diversity, equity, and inclusion.

Listen to ASCO's Journal of Clinical Oncology essay, “The Road Less Traveled: Perspective From an Australian Oncologist” by Stephanie Hui-Su Lim, Medical Oncologist at Macarthur Cancer Therapy center in New South Wales, Australia. The essay is followed by an interview with Lim and host Dr. Lidia Schapira. Lim shares her thoughts as an oncologist dealing with a patient that has decided not to continue with treatment.  TRANSCRIPT Narrator: “The Road Less Traveled: Perspective From an Australian Oncologist” by Stephanie Hui-Su Lim  He had been diagnosed with metastatic colorectal cancer in his late 30s and was responding well to first-line treatment. Physically fit, with a good tolerance to therapy, there was no stigma of sickness or telltale signs of cancer lurking around him. His partner usually attends with him, offers polite nods, few questions asked, but you could sense her underlying nervousness and fear of the unknown. Between the short phrases of broken English and the interpreter talking, consultations were usually pleasant, the right questions were asked, and I would end the consultation by asking how his family was doing back in Vietnam. Born to Chinese-Vietnamese parents in a city on the outskirts of the capital, he migrated to Australia 10 years ago. He worked hard, exercised, ate a healthy blend of an Asian and Western diet, and check-boxed all the requisites to build a good life. On this occasion, his cancer was slowly progressing although remained largely asymptomatic. His optimism stayed stable, and he kept his full-time job. I discussed switching treatment. “Do you have any questions?” As I shuffled the consent form, information sheets in Vietnamese, pathology form, imaging request, and follow-up bookings, I waited for the interpreter on the other end of the phone to speak. COVID-19 was still lingering, and our face-to-face interpreter service had largely been replaced by phone calls. My now 40-year-old patient, alone today in the clinic room, looked at me and the care coordinator, then spoke something to the phone. The voice on the other end said he has no questions, he is “keen to get on with it.” “Ok then, we'll get him to sign here, and I'll need your healthcare interpreter number too.” An exchange of words ensued, perhaps some things were repeated over. Then my patient smiled, and waited. “He says thank you doctor but he doesn't want any treatment.” It was not the answer I was expecting. I had explained his slow disease progression, multiple lines available, and good tolerability of treatment, maintaining his quality of life and maximizing survival. I had gone through the projected life expectancy at this point, which was still measured in the order of short years if we pursued all standard therapies. “Can you ask him again? That he does not want any treatment?” Perhaps the interpreter had not relayed what I said. Perhaps I had not emphasized the benefits of continuing treatment. Perhaps there were misplaced reasons for declining evidence-based treatment, the clues of which I had learned to pick up quickly, gleaned from conversations over family dinners from my own family of migrants. When my patients decline treatment in a context where the clinical benefits clearly outweigh potential harm, I often feel I have not done enough. If I spent more time talking them through their decision making, guiding them through hypothetical what-if scenarios, then would we have gotten to the same page? Was I sure they were compos mentis? Should I call the other listed relatives and have the same conversation with them? In his case, he had made a capable and informed decision. We are used to the well-trodden path of exhausting appropriate standard treatment before transitioning to a best supportive care approach. However, when patients choose the less traveled path where their cancer journey and life expectancy are truncated by choice, we may struggle to understand their decision. I felt a sense of frustration at his polite declining of potential years of life and unfairness when the next patient, unfit and exhausted of all therapies, begged for more treatment options or anything that could give them another extra day. I sought to try to better understand the reasoning behind his decision. I have encountered many culturally and linguistically diverse (CALD) patients throughout my journey as an oncologist and personal experiences in my own migrant family. Our health district has one of the most diverse populations in the state, with one in 10 having limited English proficiency. Almost half the population speak a language other than English.1 We often see as many interpreters as patients in the waiting room, multiple extended family members crowding into small consult rooms, and multitude of language translations of patient booklets being the only recognizable information to new patients in an otherwise foreign cancer center. I understood the importance of cultural awareness, and that cultural differences feed into decision making. But what were the beliefs, concepts, and cultural norms that shape what they do and value? An Australian study investigating the attitudes of Chinese migrant patients toward cancer identified several key areas including the nondisclosure of a poor prognosis, importance of family in mediating between health professionals and patients, incorporation of Chinese culture–specific treatment, importance of interpreters, and psychological and spiritual support.2 Chinese patients use combat strategies on the basis of traditional Chinese medicine, Chinese beliefs of food to maintain health, exercise with Qigong, Feng Shui/spatial organization, and ancestor worship.3 Chinese illness conceptualization includes concepts of karma, fate, and retribution.4 There are recurring themes that arise, with another study highlighting the importance of the Chinese beliefs in fate and luck, ying and yang, stoicism as a coping mechanism, importance of family, fear of losing face, and denial of diagnosis as a means of protecting the family. A common thread of family playing an essential role, rather than a patient autonomy approach, was evident. There is a need to incorporate these beliefs into culturally appropriate programs.5 Sadly, not much is known about the cultural impacts on patient decision making. Research into race, culture, and ethnicity is thought to be too restrictive.6 Research investigating interventions to improve patient-centered care and participation in the treatment process in CALD has found positive effects of culturally tailored video and patient navigator interventions.7 A recent review also found patient navigation as an effective strategy in improving patient care, from screening through to diagnosis, treatment initiation, and likely also in the active treatment and survivorship phase.8 Importantly, cultural barriers were evident. An Australian study looking at CALD needs in outpatient cancer clinics highlighted the importance of recognizing language-related needs and care teams adapting practices and available resources to make it work for CALD communities.9 Work in other CALD groups has also focused on the triadic relationship between the patient, the patient's family, and physicians.10 Latin American women who were less acculturated deferred to their families or friends to make treatment decisions, highlighting the importance of familism as one of the most culturally specific values for Latinas. Loyalty and solidarity among members of the family are integral to decision making. Asian and Latino patients are seen to have a higher rate of patient passivity because of cultural norms that respect physician authority.11 A systemic review of cancer beliefs in minority populations, the majority based in United Kingdom and United States, found low health literacy, fatalism, and stoicism as common themes.12 Decision making in a systematic review, with a predominant African American minority group, found the themes of spirituality, fatalism, and acculturation to be important in the treatment decision process.13  Ultimately, all these cultural beliefs and concepts feed into how patients decide which treatment road they wish to take. Shared decision making models in ethnic minorities have taken into account human values recognized across different countries and the relation between these.14,15 As clinicians, we often focus on the disease, with the goal being to get rid of as many cancer cells as we humanly can and prolong our patient's life expectancy while maintaining quality of life. I often feel we require tangible goals which can be measured in time and percentages, hazard ratios, and survival odds at 2 or 3 years. For the patient sitting on the opposite side of the desk, who are only single points on a Kaplan-Meier curve, goals may be very different, shaped by their own cultural values and beliefs. What numerical value can we place on traveling overseas back home, enjoying conversations over family dinners, rather than going to the cancer center for the next cycle of treatment? My patient had decided his goal was to return home to his family in Vietnam. I saw him in clinic several times, each time gaining more of an understanding of his decision. I spoke to his partner, we obtained a face-to-face interpreter. We discussed culturally appropriate support groups. He was active in local community groups who provided spiritual and existential support. I enquired about herbal remedies, which he had been on preceding his cancer diagnosis and continued with our pharmacist's approval. We turned to discussing where he was going to be living in Vietnam, potential complications during the flight home, provision of a medical letter, and copies of his tests. He remained uncertain about the prospect of further treatment, that it was hard to access good medical care and did not offer any answers about whether he planned to seek out treatment in the big city hospitals back home. He reassured me he would be fine. Every time I see a CALD patient, I remember my patient who politely said no, thank you. I wondered if he ever accessed any treatment, how quickly his disease progressed, when and how he died. My initial frustration has evolved into the understanding of how important it was for him to be surrounded by family. I found solace knowing he died with family by his side. The treatment he wanted could not be offered through an intravenous drip or medication. It could only be found in the safe familiarity of family. Every time I see a CALD patient, I try to create a culturally familiar place for them to be treated and place their decision making amid their cultural beliefs, norms, and values. The theme of last year's World Cancer Day is “Close The Care Gap.” Language, literacy, ethnicity, race, income, education, socioeconomic status, and geographical location are just a few of the factors that contribute to the cancer care gap. We need to have cultural sensitivity in mainstream health care and respect the differences that feed into the decision to accept or decline treatment in ethnic minority groups. Ethnic minorities are defined as nondominant groups, connected by a shared cultural heritage, values, and often language. It is important to note that this is also a relative definition, and my patient in Australia falls into the CALD group, but would be the dominant group back in his home country of Vietnam. Health and illness are not only visceral but also a social and cultural phenomenon. Sometimes, it is recognizing that closing the care gap does not bring us to the same destination, but to walk the road less traveled with them. As the years pass and I reflect on my patient's cancer journey, I have come to understand that as his doctor, it was my job to ensure he understood his disease and treatment options. However, perhaps even more importantly as his doctor, it was my honor to support him down the path he had chosen. Dr. Lidia Schapira: Hello and welcome to JCO's Cancer stories, the Art of Oncology, which features essays and personal reflections from authors exploring their experience in the field of oncology. I'm your host, Dr. Lidia Schapira. I'm a Professor of Medicine at Stanford University. With me today is Dr. Stephanie Lim, a Medical Oncologist at Macarthur Cancer Therapy center in New South Wales, Australia. In this episode, we will be discussing her Art of Global Oncology article, “The Road Less Traveled: Perspective from an Australian Oncologist”.   At the time of this recording, our guest has no disclosures.  Steph, welcome to our podcast, and thank you for joining us. Dr. Stephanie Lim: Thank you very much for having me. Dr. Lidia Schapira: Let's start by talking a little bit about the role of writing and reflection for us in oncology practice. Tell us a little bit about what led you to write this case up and then to decide to share it with your colleagues.  Dr. Stephanie Lim: Yeah, so writing is definitely a creative outlet for me. I also love to paint, and I think there's so much art in the oncology space. There's so much storytelling, the rich and diverse stories that our patients live out in their cancer journey. So I think for me, writing definitely is an avenue for me to process the patient scenarios, to distill what I've experienced emotionally with the patient in front of me, and really to put it down on paper. It's almost a debriefing exercise as well for me sometimes. It's quite cathartic to write and to paint, and I find it's also a way to remember a patient. So if there's something I really don't want to forget, I think writing is a way to almost memorialize that patient's scenario and that patient experience. Dr. Lidia Schapira: Very beautifully said. So with that, let's go to the case in the particular patient that you chose to write about. And in my reading of your essay, I think you have a message. What is that message for the reader?  Dr. Stephanie Lim: So I think let's take a step back and just go through some of the themes that really resonated with me, that took me quite a few years to go through and think through before I actually wrote it down in this essay. In fact, this essay is an amalgamation of quite a few cultural and linguistically diverse, or CALD patients that I've met and looked after over the years, and those themes just kept recurring.  The first is patients when they said no to treatment. As a clinician, I struggle. I struggle with that when patients flatly refuse what I sincerely feel is the best treatment option for them. I feel frustration, disappointment, even anger and sadness, almost grieving that lost opportunity for potential life lengthening years that the patients may otherwise have. In fact, I was listening to one of your other podcasts the other day, “Knuckleheads”, which, again, resonated with me because it was, again about another story of patient refusal and a different story, but the same theme. And I think when you add the CALD population into it, which is really the theme, the message of this essay, you add another layer of complexity, another layer of cultural diversity and differences to an already complex decision making process. So those two things really sort of challenged me over the years.  And I think the other pervasive theme is that human side. We always talk about the art of oncology, the humanistic aspect, but it's true. So I think the importance of the patient's story and really just paying attention to the background and that lived experience. Someone once told me, medicine, it's a humanistic enterprise, it's not just about numbers and medians. In fact, in the essay I mentioned that the patient in front of me is really just one point on a Kaplan–Meier curve. Medians to them don't really mean very much. There's really no value that we can place on time spent with family. Or in this case, when I tell a patient they've got progression, or try and outline and map out the next treatment plan, and then they turn around and ask me, “Okay, doc. So can I hop on a plane, fly across to the other side of the world and spend three months with my family? Because that's what I want to do.” So I think there's that struggle of trying to really do what's best for the patient in terms of medians and survival and quality of life, but also trying to balance those things that are really hard to put a value on.  I hope the message of this essay is that we can try and understand, identify these things, pay attention to patients, listen to their stories, and really help appreciate those choices. So it's certainly by listening to them and really trying to understand more about CALD and the concepts and values behind their decision making. I've grown to appreciate the choices they make and really helped to support them down what I called the path less traveled, a very unfamiliar path that I otherwise wouldn't have chosen for them.  Dr. Lidia Schapira: So let's unpack all of these wisdoms that you've just told us about. The motivation is clear, the intentions are clear. Let's talk a little bit about your discomfort as an oncologist, because I'm sure our readers and our listeners have experienced that when a patient gives you an informed decision to refuse treatment, why do you think it makes us so uncomfortable? And why did it make you so uncomfortable to have your patient say, “Thank you very much, I understand you, but no thanks”? Dr. Stephanie Lim: Yeah, I think as clinicians we want the best for our patients. And I think a lot of the time that is what's best in terms of survival, what the evidence says we should be doing, weighing up the pros and cons of treatment. And we map out the lines of treatment for our patients while trying to maintain a quality of life and take into account all their wishes, of course. But I think sometimes we might get carried away with what we want for them or what we feel is best for them. But listening, if you really spend time asking what they really want, it might be something as simple as I just want to spend more time with my family rather than coming to the chemo suite for another infusion. I think as time goes on I'm doing a lot more listening, a lot less talking.  When I started out I was telling patients medians and this is what we're going to expect, this is the 50% survival rates, and a lot of time patients look at me and it means not very much to them. So I think for us there is a root that in our minds we've mapped out for them which we sincerely feel is the best for them. And I think when they refuse that it can be quite frustrating, but also I think, challenging because as I said, it's a path that's unfamiliar. When patients go from diagnosis to, “Well, I actually don't want any treatment,” really they shorten their- as I think I put in the essay, intentionally shortening their survival and choosing best supportive care when they're not there yet is something that I still struggle with, especially in my younger patients. Dr. Lidia Schapira: So let's talk a little bit about that. And I'm just challenging you in the best possible collegial way here when we talk about honoring our patients autonomy and providing sufficient information for them to really give us informed consent based on being aware of their choices and trade offs. And yet when those decisions don't conform to what we think we would choose or what we've recommended, there's disquiet. And yes, we know that the patient ultimately is the main decider on what gives their life value and meaning, but it's difficult for us. Can you talk a little bit about how you resolve this tension in your practice? Even if a patient is very fluent in your primary language, that's almost a detail. It complicates things here. But it's not the only thing that really, I think, is so challenging and feels so difficult sometimes for the oncologist.  Dr. Stephanie Lim: Yes, I think in the CALD population, there's several other layers of complexity. So yes, the patient is ultimately the person receiving treatment and yes, they are the ones who should be deciding what they want. I think in the CALD population it's more complex because we talk about patient and clinician shared decision making, but there is this triad of family physician and patient relationship that exists in a lot of CALD populations, not only in Southeast Asian or South Asian, but perhaps even in the Latin American population, and that importance of families. So there is not just a patient and a physician, but there is also the whole family that is making that decision.  To complicate things in Asian culture, there is also this autonomy that's given to the doctor. So that belief that the decision making in some ways should be delegated to the health professional because they're the ones who know what they're doing. And a lot of my Asian patients might say, “Well, you're the doctor. You should be telling me what to do.” So I think it's a balance between respecting that, if that is their belief, respecting that doctor autonomy, but also taking into account that triad of decision making with patients, family, and even the wider community. So I think certainly in a CALD population, my approach would be to really understand why they've made that decision, to involve the family in that decision making, perhaps to see the patient over time, over multiple consultations, which we've done with this particular patient in the essay, and really just to understand what the barriers are or what their reasons are for going down a different path to what I've recommended. And I think once that's all unpacked, I think it becomes quite clear and it gets us to the same page. Dr. Lidia Schapira: So, Steph, if this patient had been 65 or older, do you think it would have been easier for you to accept his decision to say ‘no' to treatment and go home to be with family, whether or not access to any treatment is available to him there? Dr. Stephanie Lim: That's a good point. I think I personally do struggle more in my younger patients, patients closer in age to me at a similar stage of life, they have young children, and I think a lot of it is because they are so fit. We feel that they can tolerate so many lines of treatment. I'm almost grieving that lost opportunity, lost time that they may have with their children or their family. So I think definitely in the younger patients, it resonates with me more. I struggle more with that. Having said that, it's still a struggle when older patients who are fit for treatment say ‘no'. But definitely, I agree with you. I think the younger patients definitely are harder to manage.  Dr. Lidia Schapira: I was very impressed in reading your essay with the fact that you remained curious about the person who was your patient. You were curious and engaged and wanted to learn what he was thinking. And you not only wanted to make sure that he understood his options medically, but you wanted to understand the context, as you say, who else was influencing the decision, and still wanted to preserve the relationship. Tell us a little bit about how that evolved over time and what you learned and how you brought yourself to a place where you could accept this, at least not be distressed by his refusal of treatment.  Dr. Stephanie Lim: So I think, again, a lot of it was listening to his stories. Over time, that conversation shifted from me trying to tell him that if you have this treatment, this is what we expect, this is what we could gain. These are the survival years that you potentially could benefit from. So I think the conversation, over time, shifted from that to a focus on his values, other support systems, whether it's the support communities that were in place, the importance of even complementary or Chinese medicines that he was also pursuing, basically trying to unpack all that. And I think our conversations shifted from a lot less talk about treating the cancer to treating him as a person and what he needed.  So I think over time, I basically sat back and listened to him and what he wished to do. And over time, that conversation then evolved into, “Okay, you're going to leave, so how can I best support you?” And even then, I was trying to see if he was going to seek treatment overseas. I was ready to call someone at the other end of the world to say, “Here are the medical records. This is what can be done for him.” But I think over time, I've come to realize that definitely was not his priority. He needed to be with family. He wanted to go home. And as a clinician, as his treating clinician, I think my job was to support him through that and try and understand. So I think over time, just spending that time listening to them, I did understand. I did struggle with it. But I think ultimately, I was at peace with his decision.  Dr. Lidia Schapira: In the essay, you mentioned that your family also migrated to Australia. Do you think that their experience in some way has shaped your attitude towards understanding cultural and linguistic differences? And if so, how?  Dr. Stephanie Lim: Yeah, thanks for asking that, Lidia. So I was born in Southeast Asia. In fact, I grew up in Brunei, on Borneo island, which is in the heart of Southeast Asia. My dad is Bruneian. My mom is Malaysian. I did finish off my high school in Australia and did all my medical training in Australia. So this is through an Australian lens. In fact, the reviewers wanted me to include that, to point out that CALD is a very relative definition. But I think I class myself as a 1.5 generation Australian. So I hope that I do have some insights from my background and my upbringing to understand a little bit more about the nuances, to be able to pick out some of the subtleties when I see patients, when I talk to patients, that complex cultural belief that underpins all their decision making. So I think that definitely, I hope, has enabled me to be more sensitive and to be able to pick out some of those nuances that helps me better understand and frame a patient's decision making. Dr. Lidia Schapira: And ultimately, did you feel all right with your decision and your patient's decision? Dr. Stephanie Lim: Yes, I did. So I think ultimately, the goal is to create this culturally safe and appropriate place for patients where they're comfortable, where the clinicians are also comfortable with that final decision that we reached. And I think we got there. But my hope is that with all future patients, that we can create this with the help of patient care navigators, patient translators. It comes from a systems level, a team level, and definitely an individual level to understand, identify these concepts, as I pointed out in the essay, to reach a point where we feel that the patients have had a culturally safe and language appropriate care, that we've explored all the avenues, all their concepts, all their beliefs, and we've reached the decision that we're both comfortable with. Dr. Lidia Schapira: Well, Steph, it's been a pleasure to chat with you today, and I know that I did, and I know my colleagues have learned a lot from reading your story and wish you all the best. And thank you for sending your work to JGO. Dr. Stephanie Lim: Thank you, Lidia, it was a pleasure chatting to you. Dr. Lidia Schapira: And until next time, thank you for listening to JCO's Cancer Stories, The Art of Oncology. Don't forget to give us a rating or review, and be sure to subscribe so you never miss an episode. You can find all of ASCO shows asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

In an exclusive conversation with SBS Hindi, Victoria Police's Protective Service Officer (PSO) Mohammad Ali discusses the benefits of a career in public service and offers valuable tips for successfully navigating the recruitment process. Tune in to gain insights into what a typical day in the life of a Victoria Police officer entails.